bluebird bio Inc (BLUE)
0.9125
-0.01
(-1.13%)
USD |
NASDAQ |
Apr 25, 16:00
0.9125
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Free Cash Flow (Quarterly): -63.88M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -63.88M |
| June 30, 2023 | -73.43M |
| March 31, 2023 | -87.74M |
| December 31, 2022 | -61.38M |
| September 30, 2022 | -78.29M |
| June 30, 2022 | -100.34M |
| March 31, 2022 | -126.15M |
| December 31, 2021 | -141.78M |
| September 30, 2021 | -156.68M |
| June 30, 2021 | -149.23M |
| March 31, 2021 | -210.95M |
| December 31, 2020 | -163.08M |
| September 30, 2020 | -154.40M |
| June 30, 2020 | 34.94M |
| March 31, 2020 | -216.80M |
| December 31, 2019 | -172.37M |
| September 30, 2019 | -138.32M |
| June 30, 2019 | -156.48M |
| March 31, 2019 | -173.48M |
| December 31, 2018 | -142.62M |
| September 30, 2018 | -96.63M |
| June 30, 2018 | -113.64M |
| March 31, 2018 | -116.27M |
| December 31, 2017 | -114.21M |
| Date | Value |
|---|---|
| September 30, 2017 | -60.24M |
| June 30, 2017 | -67.02M |
| March 31, 2017 | -101.33M |
| December 31, 2016 | -82.13M |
| September 30, 2016 | -48.39M |
| June 30, 2016 | -46.50M |
| March 31, 2016 | -40.66M |
| December 31, 2015 | -36.52M |
| September 30, 2015 | -30.12M |
| June 30, 2015 | -13.53M |
| March 31, 2015 | -25.32M |
| December 31, 2014 | -18.07M |
| September 30, 2014 | -22.54M |
| June 30, 2014 | -13.34M |
| March 31, 2014 | -14.45M |
| December 31, 2013 | -10.74M |
| September 30, 2013 | -10.98M |
| June 30, 2013 | -8.706M |
| March 31, 2013 | 65.21M |
| December 31, 2012 | -6.992M |
| September 30, 2012 | -4.263M |
| June 30, 2012 | -4.165M |
| March 31, 2012 | -6.491M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-216.80M
Minimum
Mar 2020
34.94M
Maximum
Jun 2020
-123.13M
Average
-140.05M
Median
Free Cash Flow (Quarterly) Benchmarks
| Novavax Inc | -185.86M |
| Motus GI Holdings Inc | -1.856M |
| Tivic Health Systems Inc | -1.774M |
| Vertex Pharmaceuticals Inc | 118.50M |
| AIM ImmunoTech Inc | -9.956M |